Meeting
2015 ASCO Annual Meeting
The clinical utility of ERBB2 amplification detection in breast carcinoma using a 341 gene hybrid capture-based next generation sequencing (NGS) assay: Comparison with standard immunohistochemistry (IHC) and Fluorescence In Situ Hybridization (FISH) assays.
Authors
Dara S. Ross
Memorial Sloan Kettering Cancer Center, New York, NY
Dara S. Ross , Ahmet Zehir , Donavan T. Cheng , Khedoudja Nafa , George Jour , Pedram Razavi , David Michael Hyman , Jose Baselga , Michael F. Berger , Marc Ladanyi , Maria E. Arcila
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—HER2/ER
Track
Breast Cancer
Sub Track
HER2+
Citation
J Clin Oncol 33, 2015 (suppl; abstr 604)
DOI
10.1200/jco.2015.33.15_suppl.604
Abstract #
604
Poster Bd #
93
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Molecular genetic sequencing of neuroendocrine tumors of the gastrointestinal tract.
First Author: Alexandra Androsova
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Molecular landscape and clinical implication of CCNE1-amplified esophagogastric cancer.
First Author: Ryan H. Moy
Poster
2022 ASCO Annual Meeting
Clinicopathologic and molecular features associated with response to anti-HER2 therapy in endometrial cancer.
First Author: Sherry Shen
First Author: Neal A. Fischbach